Baidu
map

指南&解读

订阅

MedSci主页 / 所有栏目 / 指南&解读

2011年NCCN乳腺癌风险控制临床诊断指南

2011-04-05 MedSci原创 MedSci原创

NCCN乳腺癌风险指南
关注

Breast Cancer Risk Reduction.pdf

Breast Cancer Risk Reduction.pdf

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=37434, encodeId=d12f3e434f4, content=And I thought I was the sensible one. Thanks for setting me sttiaghr., beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cristiane, createdTime=Sun Sep 27 08:20:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2061293, encodeId=d051206129367, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sat Mar 03 22:09:00 CST 2012, time=2012-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2850, encodeId=7b7a2850da, content=好，太好了啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cdb44543, createdName=tyndall, createdTime=Tue Aug 23 21:48:00 CST 2011, time=2011-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770188, encodeId=95671e701884d, content=<a href='/topic/show?id=df9c23e868a' target=_blank style='color:#2F92EE;'>#乳腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23786, encryptionId=df9c23e868a, topicName=乳腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9538161180, createdName=gaoxiaoe, createdTime=Sun Oct 30 14:09:00 CST 2011, time=2011-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1319658, encodeId=f90513196588e, content=<a href='/topic/show?id=c806125e30b' target=_blank style='color:#2F92EE;'>#NCCN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12573, encryptionId=c806125e30b, topicName=NCCN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Thu Apr 07 05:09:00 CST 2011, time=2011-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543259, encodeId=228d1543259b0, content=<a href='/topic/show?id=08ef230191c' target=_blank style='color:#2F92EE;'>#临床诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23019, encryptionId=08ef230191c, topicName=临床诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c35213562602, createdName=ms5906905816781247, createdTime=Thu Apr 07 05:09:00 CST 2011, time=2011-04-07, status=1, ipAttribution=)]
    2015-09-27 cristiane

    And I thought I was the sensible one. Thanks for setting me sttiaghr.

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=37434, encodeId=d12f3e434f4, content=And I thought I was the sensible one. Thanks for setting me sttiaghr., beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cristiane, createdTime=Sun Sep 27 08:20:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2061293, encodeId=d051206129367, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sat Mar 03 22:09:00 CST 2012, time=2012-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2850, encodeId=7b7a2850da, content=好，太好了啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cdb44543, createdName=tyndall, createdTime=Tue Aug 23 21:48:00 CST 2011, time=2011-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770188, encodeId=95671e701884d, content=<a href='/topic/show?id=df9c23e868a' target=_blank style='color:#2F92EE;'>#乳腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23786, encryptionId=df9c23e868a, topicName=乳腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9538161180, createdName=gaoxiaoe, createdTime=Sun Oct 30 14:09:00 CST 2011, time=2011-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1319658, encodeId=f90513196588e, content=<a href='/topic/show?id=c806125e30b' target=_blank style='color:#2F92EE;'>#NCCN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12573, encryptionId=c806125e30b, topicName=NCCN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Thu Apr 07 05:09:00 CST 2011, time=2011-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543259, encodeId=228d1543259b0, content=<a href='/topic/show?id=08ef230191c' target=_blank style='color:#2F92EE;'>#临床诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23019, encryptionId=08ef230191c, topicName=临床诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c35213562602, createdName=ms5906905816781247, createdTime=Thu Apr 07 05:09:00 CST 2011, time=2011-04-07, status=1, ipAttribution=)]
    2012-03-03 sjq027

    #癌风险#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=37434, encodeId=d12f3e434f4, content=And I thought I was the sensible one. Thanks for setting me sttiaghr., beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cristiane, createdTime=Sun Sep 27 08:20:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2061293, encodeId=d051206129367, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sat Mar 03 22:09:00 CST 2012, time=2012-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2850, encodeId=7b7a2850da, content=好，太好了啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cdb44543, createdName=tyndall, createdTime=Tue Aug 23 21:48:00 CST 2011, time=2011-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770188, encodeId=95671e701884d, content=<a href='/topic/show?id=df9c23e868a' target=_blank style='color:#2F92EE;'>#乳腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23786, encryptionId=df9c23e868a, topicName=乳腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9538161180, createdName=gaoxiaoe, createdTime=Sun Oct 30 14:09:00 CST 2011, time=2011-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1319658, encodeId=f90513196588e, content=<a href='/topic/show?id=c806125e30b' target=_blank style='color:#2F92EE;'>#NCCN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12573, encryptionId=c806125e30b, topicName=NCCN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Thu Apr 07 05:09:00 CST 2011, time=2011-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543259, encodeId=228d1543259b0, content=<a href='/topic/show?id=08ef230191c' target=_blank style='color:#2F92EE;'>#临床诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23019, encryptionId=08ef230191c, topicName=临床诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c35213562602, createdName=ms5906905816781247, createdTime=Thu Apr 07 05:09:00 CST 2011, time=2011-04-07, status=1, ipAttribution=)]
    2011-08-23 tyndall

    好，太好了啊

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=37434, encodeId=d12f3e434f4, content=And I thought I was the sensible one. Thanks for setting me sttiaghr., beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cristiane, createdTime=Sun Sep 27 08:20:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2061293, encodeId=d051206129367, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sat Mar 03 22:09:00 CST 2012, time=2012-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2850, encodeId=7b7a2850da, content=好，太好了啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cdb44543, createdName=tyndall, createdTime=Tue Aug 23 21:48:00 CST 2011, time=2011-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770188, encodeId=95671e701884d, content=<a href='/topic/show?id=df9c23e868a' target=_blank style='color:#2F92EE;'>#乳腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23786, encryptionId=df9c23e868a, topicName=乳腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9538161180, createdName=gaoxiaoe, createdTime=Sun Oct 30 14:09:00 CST 2011, time=2011-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1319658, encodeId=f90513196588e, content=<a href='/topic/show?id=c806125e30b' target=_blank style='color:#2F92EE;'>#NCCN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12573, encryptionId=c806125e30b, topicName=NCCN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Thu Apr 07 05:09:00 CST 2011, time=2011-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543259, encodeId=228d1543259b0, content=<a href='/topic/show?id=08ef230191c' target=_blank style='color:#2F92EE;'>#临床诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23019, encryptionId=08ef230191c, topicName=临床诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c35213562602, createdName=ms5906905816781247, createdTime=Thu Apr 07 05:09:00 CST 2011, time=2011-04-07, status=1, ipAttribution=)]
    2011-10-30 gaoxiaoe

    #乳腺癌风险#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=37434, encodeId=d12f3e434f4, content=And I thought I was the sensible one. Thanks for setting me sttiaghr., beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cristiane, createdTime=Sun Sep 27 08:20:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2061293, encodeId=d051206129367, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sat Mar 03 22:09:00 CST 2012, time=2012-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2850, encodeId=7b7a2850da, content=好，太好了啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cdb44543, createdName=tyndall, createdTime=Tue Aug 23 21:48:00 CST 2011, time=2011-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770188, encodeId=95671e701884d, content=<a href='/topic/show?id=df9c23e868a' target=_blank style='color:#2F92EE;'>#乳腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23786, encryptionId=df9c23e868a, topicName=乳腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9538161180, createdName=gaoxiaoe, createdTime=Sun Oct 30 14:09:00 CST 2011, time=2011-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1319658, encodeId=f90513196588e, content=<a href='/topic/show?id=c806125e30b' target=_blank style='color:#2F92EE;'>#NCCN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12573, encryptionId=c806125e30b, topicName=NCCN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Thu Apr 07 05:09:00 CST 2011, time=2011-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543259, encodeId=228d1543259b0, content=<a href='/topic/show?id=08ef230191c' target=_blank style='color:#2F92EE;'>#临床诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23019, encryptionId=08ef230191c, topicName=临床诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c35213562602, createdName=ms5906905816781247, createdTime=Thu Apr 07 05:09:00 CST 2011, time=2011-04-07, status=1, ipAttribution=)]
    2011-04-07 旅苦化文_208

    #NCCN#

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=37434, encodeId=d12f3e434f4, content=And I thought I was the sensible one. Thanks for setting me sttiaghr., beContent=null, objectType=article, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=cristiane, createdTime=Sun Sep 27 08:20:00 CST 2015, time=2015-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2061293, encodeId=d051206129367, content=<a href='/topic/show?id=e6e1e15509f' target=_blank style='color:#2F92EE;'>#癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71550, encryptionId=e6e1e15509f, topicName=癌风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d58a435, createdName=sjq027, createdTime=Sat Mar 03 22:09:00 CST 2012, time=2012-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2850, encodeId=7b7a2850da, content=好，太好了啊, beContent=null, objectType=article, channel=null, level=null, likeNumber=132, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7cdb44543, createdName=tyndall, createdTime=Tue Aug 23 21:48:00 CST 2011, time=2011-08-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770188, encodeId=95671e701884d, content=<a href='/topic/show?id=df9c23e868a' target=_blank style='color:#2F92EE;'>#乳腺癌风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23786, encryptionId=df9c23e868a, topicName=乳腺癌风险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4a9538161180, createdName=gaoxiaoe, createdTime=Sun Oct 30 14:09:00 CST 2011, time=2011-10-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1319658, encodeId=f90513196588e, content=<a href='/topic/show?id=c806125e30b' target=_blank style='color:#2F92EE;'>#NCCN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12573, encryptionId=c806125e30b, topicName=NCCN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Thu Apr 07 05:09:00 CST 2011, time=2011-04-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1543259, encodeId=228d1543259b0, content=<a href='/topic/show?id=08ef230191c' target=_blank style='color:#2F92EE;'>#临床诊断#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=23019, encryptionId=08ef230191c, topicName=临床诊断)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c35213562602, createdName=ms5906905816781247, createdTime=Thu Apr 07 05:09:00 CST 2011, time=2011-04-07, status=1, ipAttribution=)]
    2011-04-07 ms5906905816781247

    #临床诊断#

    0

相关资讯

2011年NCCN食管癌临床实践指南

食管癌2011nccn指南.pdf

2011年NCCN颈部肿瘤临床实践指南

颈部肿瘤2011nccn指南.pdf

2011年NCCN原发灶不明肿瘤临床实践指南

原发灶不明肿瘤2011nccn指南.pdf

2010年NCCN乳腺癌筛查与诊断临床实践指南

Breast Cancer Screening and Diagnosis.pdf

2011年NCCN骨肿瘤临床实践指南

骨肿瘤2011nccn指南.pdf

2011年NCCN卵巢癌临床实践指南

卵巢癌2011nccn指南.pdf

Baidu
map
Baidu
map
Baidu
map